Viral Myocarditis: From the Perspective of the Virus

Viral myocarditis has been recognized as a cause of congestive heart failure for >50 years, but it is still a challenging disease to diagnose and treat.1,2 The history and clinical features are often nonspecific, and practical serological markers are not available during the acute phase of the disease. Even after proper diagnosis, no clinically proven treatment exists to inhibit the development of subsequent dilated cardiomyopathy (DCM) and, in some cases, death. Accordingly, to facilitate future scientific work into this difficult clinical entity, this review proposes a clinical paradigm that focuses on the phases of viral infection and the molecular insights that are important for these phases of the infectious process with a focus on interactions between the virus and the cardiac myocyte. Myocarditis is defined as inflammation of the heart muscle. The gold standard for diagnosis has been the Dallas criteria based on histopathology from an endomyocardial biopsy.3 It is now recognized that the Dallas criteria are not sensitive for myocarditis because they do not consider the presence of viral genome in the heart.4 Furthermore, an invasive procedure is required to obtain a sample of the myocardium. Many viruses have been implicated as causes of myocarditis. These most commonly include adenoviruses and enteroviruses such as the coxsackieviruses. Recently, parvovirus B19 has been associated with a significant percentage of patients diagnosed with myocarditis and DCM.5 However, a growing body of data indicates that parvovirus is present in a large percentage of patients who do not have myocarditis.6–8 Of the viruses that cause myocarditis, the cellular and molecular mechanisms associated with coxsackieviral infection of the heart have been most thoroughly investigated with murine models. Therefore, the mechanistic experiments described in this review focus primarily, but not exclusively, on coxsackieviral myocarditis. It is important to note that coxsackieviruses …

[1]  V. Kytö,et al.  Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Karupiah,et al.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. , 1993, Science.

[3]  S. Akira,et al.  Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production , 2005, Circulation.

[4]  B. McManus,et al.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[5]  S. Akira,et al.  Toll-Like receptors (TLRs) and their ligands. , 2008, Handbook of experimental pharmacology.

[6]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[7]  M. Beck,et al.  Selenium deficiency and viral infection. , 2003, The Journal of nutrition.

[8]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[9]  K. Beisel,et al.  Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. , 1987, Journal of the American College of Cardiology.

[10]  M. Halks-Miller,et al.  Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[11]  K. Klingel,et al.  Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. , 2009, Journal of the American College of Cardiology.

[12]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[13]  I. Komuro,et al.  Active myocarditis in a patient with chronic active Epstein-Barr virus infection. , 2008, International journal of cardiology.

[14]  K. Klingel,et al.  Cardioselective Infection With Coxsackievirus B3 Requires Intact Type I Interferon Signaling: Implications for Mortality and Early Viral Replication , 2001, Circulation.

[15]  P. Godowski,et al.  Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines , 2002, The Journal of Immunology.

[16]  B. Ferry,et al.  Unusual case presentations associated with the CD45 C77G polymorphism , 2006, Clinical and experimental immunology.

[17]  Y. Yang,et al.  Localization of Enteroviral Antigen in Myocardium and Other Tissues from Patients with Heart Muscle Disease by an Improved Immunohistochemical Technique , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  J. Towbin,et al.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.

[19]  C. Badorff,et al.  Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: A genetic predisposition to viral heart disease , 2002, Nature Medicine.

[20]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Mak,et al.  The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease , 2000, Nature Medicine.

[22]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[23]  T. Mak,et al.  Susceptibility to Myocarditis Is Dependent on the Response of αβ T Lymphocytes to Coxsackieviral Infection , 1999 .

[24]  M. Herregods,et al.  Pseudoaneurysm of the left ventricle with moderate left-to-right shunt. , 2008, International journal of cardiology.

[25]  J. Tomassini,et al.  cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Sall,et al.  Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1 , 2007, Apoptosis.

[28]  N. Bowles,et al.  Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy. , 2002, Molecular genetics and metabolism.

[29]  N. Rose,et al.  IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication1 , 2003, The Journal of Immunology.

[30]  A. Yoshimura,et al.  Innate Defense Mechanism Against Virus Infection Within the Cardiac Myocyte Requiring gp130-STAT3 Signaling , 2006, Circulation.

[31]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[32]  M. Dan,et al.  A Genetically Engineered Attenuated Coxsackievirus B3 Strain Protects Mice against Lethal Infection , 2005, Journal of Virology.

[33]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[34]  J. Melnick,et al.  Adenovirus myocarditis in mice. An electron microscopic study. , 1968, Experimental and molecular pathology.

[35]  Chen Chen,et al.  The tight junction protein CAR regulates cardiac conduction and cell–cell communication , 2008, The Journal of experimental medicine.

[36]  K. Baughman Diagnosis of myocarditis: death of Dallas criteria. , 2006, Circulation.

[37]  S. Vidal,et al.  Complex genetic control of host susceptibility to coxsackievirus B3-induced myocarditis , 2007, Genes and Immunity.

[38]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[39]  R. Hetzer,et al.  Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins αvβ3 and αvβ5 on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy Implications for Cardiotropic Viral Infections , 2001 .

[40]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[41]  M. Beck,et al.  Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates , 1995, Nature Medicine.

[42]  J. Bergelson,et al.  Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions , 2006, Cell.

[43]  K. Klingel,et al.  Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. , 2003, Human pathology.

[44]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[45]  V. de Giorgi,et al.  Tissue persistence of parvovirus B19 genotypes in asymptomatic persons , 2008, Journal of medical virology.

[46]  N. Chapman,et al.  Coxsackievirus Expression of the Murine Secretory Protein Interleukin-4 Induces Increased Synthesis of Immunoglobulin G1 in Mice , 2000, Journal of Virology.

[47]  Hong-Hsing Liu,et al.  The specific and essential role of MAVS in antiviral innate immune responses. , 2006, Immunity.

[48]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[49]  M. Nishimura,et al.  Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. , 2005, Biological & pharmaceutical bulletin.

[50]  S. Pollak,et al.  High Prevalence of Human Parvovirus B19 DNA in Myocardial Autopsy Samples from Subjects without Myocarditis or Dilative Cardiomyopathy , 2008, Journal of Clinical Microbiology.

[51]  M. Weitzman,et al.  The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. , 2003, The Journal of clinical investigation.

[52]  E. Fish,et al.  Protective Role for Interferon-&bgr; in Coxsackievirus B3 Infection , 2004, Circulation.

[53]  R. Hetzer,et al.  Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. , 2001, Circulation.

[54]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[55]  R. Zell,et al.  Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis , 2001, Journal of Virology.

[56]  J. Hiscott,et al.  MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.

[57]  J. Hoffmann,et al.  The immune response of Drosophila , 2003, Nature.

[58]  R. Rhoads,et al.  Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. , 1993, The Journal of biological chemistry.

[59]  M. Comar,et al.  HHV‐6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines , 2002, Journal of medical virology.

[60]  N. Dalton,et al.  Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. , 1998, The Journal of clinical investigation.

[61]  R. Flavell,et al.  Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. , 2007, American journal of physiology. Heart and circulatory physiology.

[62]  B. McManus,et al.  Human leukocyte antigen class ii associations in patients with idiopathic dilated cardiomyopathy , 1997 .

[63]  Z. Zhai,et al.  VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.

[64]  T. Mak,et al.  Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. , 1999, Circulation research.

[65]  N. Dalton,et al.  Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy , 2006, Circulation.

[66]  G. Nuovo,et al.  Histologic and In Situ Viral Findings in the Myocardium in Cases of Sudden, Unexpected Death , 2002, Modern Pathology.

[67]  D. Golenbock,et al.  Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll‐like receptor (TLR) 8‐dependent , 2005, Cellular microbiology.

[68]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[69]  R. Kuwano,et al.  Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat , 2004, Virchows Archiv.

[70]  S. Cusack,et al.  Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. , 2000, Structure.

[71]  Michael Böhm,et al.  Predictors of Outcome in Patients With Suspected Myocarditis , 2008, Circulation.

[72]  C. Coban,et al.  Essential role of IPS-1 in innate immune responses against RNA viruses , 2006, The Journal of experimental medicine.

[73]  Heribert Schunkert,et al.  Left-ventricular dysfunction , 1998, The Lancet.

[74]  M. Russo,et al.  Intramyocyte Detection of Epstein-Barr Virus Genome by Laser Capture Microdissection in Patients With Inflammatory Cardiomyopathy , 2004, Circulation.

[75]  M. Beck,et al.  Benign human enterovirus becomes virulent in selenium‐deficient mice , 1994, Journal of medical virology.

[76]  J. Mira,et al.  A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection , 2000, Infection and Immunity.

[77]  P. Poole‐Wilson,et al.  Myocarditis--continuing clinical and pathologic confusion. , 1991, American heart journal.

[78]  A. McCulloch,et al.  Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. , 2008, The Journal of clinical investigation.

[79]  M. Comar,et al.  Human herpesvirus‐6 modulates RANTES production in primary human endothelial cell cultures , 2003, Journal of medical virology.

[80]  Shizuo Akira,et al.  Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.

[81]  H. Schultheiss,et al.  Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.

[82]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[83]  G. Kollias,et al.  Role of the Innate Immune System in Acute Viral Myocarditis , 2009, Basic Research in Cardiology.

[84]  G. Barbarini,et al.  Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. , 1998, The New England journal of medicine.

[85]  S. Modrow,et al.  Adaptive immune responses against parvovirus B19 in patients with myocardial disease. , 2009, Journal of Clinical Virology.

[86]  A. Matsumori,et al.  Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. , 1988, American heart journal.

[87]  J. Darnell STATs and gene regulation. , 1997, Science.

[88]  S. Huber VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells , 1994, Journal of virology.

[89]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[90]  A. Takeda,et al.  Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy , 1999, Molecular and Cellular Biochemistry.

[91]  L. Philipson,et al.  The coxsackie-adenovirus receptor--a new receptor in the immunoglobulin family involved in cell adhesion. , 2004, Current topics in microbiology and immunology.

[92]  Josef M. Penninger,et al.  CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling , 2001, Nature.

[93]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[94]  D. Schwartz,et al.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. , 2002, Archives of internal medicine.

[95]  N. Rose,et al.  IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. , 2003, Journal of immunology.

[96]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.

[97]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[98]  M. Halks-Miller,et al.  Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[99]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[100]  B. McManus,et al.  The impact of CVB3 infection on host cell biology. , 2008, Current topics in microbiology and immunology.

[101]  B. McManus,et al.  Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[102]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[103]  C. Kawai,et al.  Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. , 1985, Circulation.

[104]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.